Patents by Inventor Max A. Schwarzer

Max A. Schwarzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof
    Patent number: 10689449
    Abstract: This disclosure provides dimeric, pentameric, and hexameric Tumor Necrosis Factor (TNF) superfamily receptor protein binding molecules and methods of using such binding molecules to direct apoptosis-mediated killing of TNF receptor-expressing cells.
    Type: Grant
    Filed: January 20, 2016
    Date of Patent: June 23, 2020
    Assignee: IGM Biosciences, Inc.
    Inventors: Beatrice Tien-Yi Wang, Max A. Schwarzer, Bruce Alan Keyt, Ramesh Baliga
  • TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY RECEPTOR BINDING MOLECULES AND USES THEREOF
    Publication number: 20180009897
    Abstract: This disclosure provides dimeric, pentameric, and hexameric Tumor Necrosis Factor (TNF) superfamily receptor protein binding molecules and methods of using such binding molecules to direct apoptosis-mediated killing of TNF receptor-expressing cells.
    Type: Application
    Filed: January 20, 2016
    Publication date: January 11, 2018
    Inventors: Beatrice Tien-Yi Wang, Max A. Schwarzer, Bruce Keyt, Ramesh Baliga